Hammond CA, Wu SWei, Wang F, MacAldaz ME, Eaves CJ. Aging alters the cell cycle control and mitogenic signaling responses of human hematopoietic stem cells. Blood. 2023.
Sousa NS, Brás MF, Antunes IB, Lindholm P, Neves J, Sousa-Victor P. Aging disrupts MANF-mediated immune modulation during skeletal muscle regeneration. Nat Aging. 2023.
Wang Y, Zhang Z, He H, Song J, Cui Y, Chen Y, Zhuang Y, Zhang X, Li M, Zhang X, et al. Aging-induced pseudouridine synthase 10 impairs hematopoietic stem cells. Haematologica. 2023.
Silva S, Bicker J, Falcão A, Fortuna A. Air-liquid interface (ALI) impact on different respiratory cell cultures. Eur J Pharm Biopharm. 2023.
Anon. Albert MH, Sirait T, Eikema D-J, et al. Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study. Blood. 2022;140(14):1635-1649. Blood. 2023;141(18):2284.
Murayama E, Vivier C, Schmidt A, Herbomel P. Alcam-a and Pdgfr-α are essential for the development of sclerotome-derived stromal cells that support hematopoiesis. Nat Commun. 2023;14(1):1171.
Najafi R, Chahsetareh H, Pezeshki-Modaress M, Aleemardani M, Simorgh S, Davachi SMohammad, Alizadeh R, Asghari A, Hassanzadeh S, Bagher Z. Alginate sulfate/ECM composite hydrogel containing electrospun nanofiber with encapsulated human adipose-derived stem cells for cartilage tissue engineering. Int J Biol Macromol. 2023:124098.
Wu M, Pelacho B, Claus P, De Buck S, Veltman D, Gillijns H, Holemans P, Pokreisz P, Caluwé E, Colino EIglesias, et al. Alginate Sulfate-Nanoparticles Loaded with Hepatocyte Growth Factor and Insulin-Like Growth Factor-1 Improve left ventricular repair in a Porcine Model of Myocardial Ischemia Reperfusion Injury. Eur J Pharm Biopharm. 2023.
Li Y, Xu Z, Wang J, Pei X, Chen J, Wan Q. Alginate-based biomaterial-mediated regulation of macrophages in bone tissue engineering. Int J Biol Macromol. 2023:123246.
Ford CD, Hoda D, Lopansri BK, Parra M, Sharma P, Asch J. An Algorithm Addressing the Problem of Overdiagnoses of Clostridioides difficile Infections in Hematopoietic Stem-Cell Transplant Recipients: Effects on CDI Rates and Patient Outcomes. Transplant Cell Ther. 2023.
Dehdar K, Salimi M, Tabasi F, Dehghan S, Sumiyoshi A, Garousi M, Jamaati H, Javan M, Raoufy MReza. Allergen induces depression-like behavior in association with altered prefrontal-hippocampal circuit in male rats. Neuroscience. 2023.
Yuan T, Tan M, Xu Y, Xiao Q, Wang H, Wu C, Li F, Peng L. All-in-one smart dressing for simultaneous angiogenesis and neural regeneration. J Nanobiotechnology. 2023;21(1):38.
Del Bufalo F, Becilli M, Rosignoli C, De Angelis B, Algeri M, Hanssens L, Gunetti M, Iacovelli S, Pira GLi, Girolami E, et al. Allogeneic, donor-derived, second-generation, CD19-CAR-T cell for the treatment of pediatric relapsed/refractory BCP-ALL. Blood. 2023.
Hilal T, Mountjoy LJ. Allogeneic Hematopoietic Stem Cell Transplant for Diffuse Large B-Cell Lymphoma: Evolving Role in the Era of CAR T-Cell Therapy. Curr Oncol Rep. 2023.
Laberko A, Mukhinа A, Machneva E, Pashchenko O, Bykova T, Vahonina L, Bronin G, Skvortsova Y, Skorobogatova E, Kondratenko I, et al. Allogeneic Hematopoietic Stem Cell Transplantation Activity in Inborn Errors of Immunity in Russian Federation. J Clin Immunol. 2023.
Polomeni A, Ainaoui M, Berr A, de Bentzman N, Denis M, Friser V, Magro L, Yakoub-Agha I. [Allogeneic hematopoietic stem cell transplantation and treatment with CAR-T cells - identification of psycho-social vulnerability factors: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Bull Cancer. 2023.
Berning P, Schmitz N, Ngoya M, Finel H, Boumendil A, Wang F, Huang X-J, Hermine O, Philippe L, Couronné L, et al. Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis. Leukemia. 2023.
Xia J, Zhao Y, Chen F, Miao M, Qiu HY, Ma X, Tang XW, Wang Y, Wu XJ, Fu ZZ, et al. [Allogeneic hematopoietic stem cell transplantation in acute leukemia patients with the SET-NUP214 fusion gene: Efficacy and survival analysis]. Zhonghua Nei Ke Za Zhi. 2023;62(4):410-415.
Duda K, Wieczorkiewicz-Kabut A, Koclęga A, Zielińska P, Woźniczka K, Krzemień H, Armatys A, Helbig G. Allogeneic hematopoietic stem cell transplantation remains a feasible approach for elderly with acute myeloid leukemia: a 10-year experience. Ann Hematol. 2023.
Shinohara T, Yamamoto T, Morimoto H, Shiromoto Y, Kanatsu-Shinohara M. Allogeneic offspring produced by induction of PD-L1 in spermatogonial stem cells via self-renewal stimulation. Stem Cell Reports. 2023.
Sonntag R, Kassumeh S, Luft N, Priglinger SG, Mayer WJ. [Allogeneic simple limbal epithelial transplantation (alloSLET)-Treatment of bilateral limbal stem cell insufficiency]. Ophthalmologie. 2023.
Modi D, Alkassis S, Kim S, Kin A, Deol A, Ayash L, Ratanatharathorn V, Uberti JP. Allogeneic stem cell transplant outcomes between TBI-containing reduced intensity and myeloablative conditioning regimens for ALL in complete remission. Leuk Lymphoma. 2023:1-10.
Ishida H, Shimada H, Tanizawa A, Shimazu Y, Tachibana T, Doki N, Ara T, Matsuo Y, Nara M, Toubai T, et al. Allogeneic stem cell transplantation for children and adolescents/young adults with de novo blastic phase chronic myeloid leukemia in the tyrosine kinase inhibitor era. Am J Hematol. 2023.
Kříž T, Jungova A, Lysák D, Karas M, Hrabetova M, Sramek J, Jindra P. Allogeneic stem cell transplantation in patients with multiple myeloma-single center experience. Neoplasma. 2023.
Tung Y-L, Wang Y-L, Chang T-Y, Chiu C-C, Wen Y-C, Jaing T-H. Allogeneic stem cell transplantation without preconditioning in a child with therapy-related myelodysplastic syndrome: A case report. Medicine (Baltimore). 2023;102(6):e32770.